Lawrence D. Recht

12.3k total citations · 2 hit papers
157 papers, 6.7k citations indexed

About

Lawrence D. Recht is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Lawrence D. Recht has authored 157 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Genetics, 43 papers in Pulmonary and Respiratory Medicine and 39 papers in Molecular Biology. Recurrent topics in Lawrence D. Recht's work include Glioma Diagnosis and Treatment (69 papers), Brain Metastases and Treatment (32 papers) and Cancer, Hypoxia, and Metabolism (15 papers). Lawrence D. Recht is often cited by papers focused on Glioma Diagnosis and Treatment (69 papers), Brain Metastases and Treatment (32 papers) and Cancer, Hypoxia, and Metabolism (15 papers). Lawrence D. Recht collaborates with scholars based in United States, Germany and Canada. Lawrence D. Recht's co-authors include Michael Glantz, Bernard F. Cole, N. Scott Litofsky, J. Martin Brown, Hannes Vogel, Samuel Strober, Griffith R. Harsh, Thomas W. Smith, Marc C. Chamberlain and Alonzo H. Ross and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Lawrence D. Recht

149 papers receiving 6.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Practice parameter: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumors [RETIRED]

2000 537 citations Michael Glantz, Lawrence D. Recht et al. Neurology profile →
A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study

2015 313 citations Lawrence D. Recht et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Lawrence D. Recht	2.5k	1.9k	1.7k	1.4k	885	157	6.7k
Jennifer Clarke	2.5k 1.0×	1.2k 0.6×	1.8k 1.1×	1.4k 1.0×	978 1.1×	175	5.7k
Athanassios P. Kyritsis	2.3k 0.9×	3.2k 1.7×	1.5k 0.9×	2.0k 1.4×	1.0k 1.2×	173	7.9k
Chetan Bettegowda	1.9k 0.8×	2.3k 1.2×	1.9k 1.1×	1.7k 1.2×	1.1k 1.2×	306	8.7k
Steven Brem	2.8k 1.1×	2.9k 1.5×	1.3k 0.8×	1.5k 1.0×	626 0.7×	193	7.7k
Joshua B. Rubin	1.7k 0.7×	3.0k 1.6×	797 0.5×	1.8k 1.3×	926 1.0×	160	8.8k
Nicholas Butowski	3.5k 1.4×	2.0k 1.1×	1.3k 0.8×	1.4k 1.0×	628 0.7×	188	6.3k
Frank S. Lieberman	2.5k 1.0×	1.5k 0.8×	931 0.5×	1.6k 1.1×	709 0.8×	139	5.0k
Albert H. Kim	1.5k 0.6×	2.6k 1.4×	825 0.5×	821 0.6×	748 0.8×	152	6.3k
Johannes Wolff	3.7k 1.5×	2.9k 1.6×	1.2k 0.7×	1.4k 1.0×	1.7k 1.9×	231	7.5k
Randy L. Jensen	3.7k 1.5×	2.1k 1.1×	1.6k 0.9×	1.3k 0.9×	1.3k 1.5×	202	7.6k

Countries citing papers authored by Lawrence D. Recht

Since Specialization

Citations

This map shows the geographic impact of Lawrence D. Recht's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence D. Recht with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence D. Recht more than expected).

Fields of papers citing papers by Lawrence D. Recht

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lawrence D. Recht. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence D. Recht. The network helps show where Lawrence D. Recht may publish in the future.

Co-authorship network of co-authors of Lawrence D. Recht

This figure shows the co-authorship network connecting the top 25 collaborators of Lawrence D. Recht. A scholar is included among the top collaborators of Lawrence D. Recht based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lawrence D. Recht. Lawrence D. Recht is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lanman, Tyler, et al.. (2025). Characteristics and Outcomes of Patients With IDH-Mutant Grade 2 and 3 Gliomas After Deferred or Adjuvant Radiotherapy. Neurology. 105(1). e213797–e213797. 1 indexed citations

Moses, Abraham S., R.S. Malek, Madeleine Landry, et al.. (2024). Monitoring of cancer ferroptosis with [¹⁸F]hGTS13, a system xc- specific radiotracer. Theranostics. 15(3). 836–849. 3 indexed citations

Recht, Lawrence D., et al.. (2023). Deuterium metabolic imaging for 3D mapping of glucose metabolism in humans with central nervous system lesions at 3T. Magnetic Resonance in Medicine. 91(1). 39–50. 22 indexed citations

Sun, Jiaxin, Chirag B. Patel, Taichang Jang, et al.. (2020). High levels of ubidecarenone (oxidized CoQ10) delivered using a drug-lipid conjugate nanodispersion (BPM31510) differentially affect redox status and growth in malignant glioma versus non-tumor cells. Scientific Reports. 10(1). 13899–13899. 15 indexed citations

Thomas, Reena, Seema Nagpal, Michael Iv, et al.. (2019). Macrophage Exclusion after Radiation Therapy (MERT): A First in Human Phase I/II Trial using a CXCR4 Inhibitor in Glioblastoma. Clinical Cancer Research. 25(23). 6948–6957. 73 indexed citations

Iv, Michael, Xiaobai Liu, Andrew J. Gentles, et al.. (2019). Perfusion MRI-Based Fractional Tumor Burden Differentiates between Tumor and Treatment Effect in Recurrent Glioblastomas and Informs Clinical Decision-Making. American Journal of Neuroradiology. 40(10). 1649–1657. 29 indexed citations

Hyman, David M., Naiyer A. Rizvi, Ronald B. Natale, et al.. (2018). Phase I Study of MEDI3617, a Selective Angiopoietin-2 Inhibitor Alone and Combined with Carboplatin/Paclitaxel, Paclitaxel, or Bevacizumab for Advanced Solid Tumors. Clinical Cancer Research. 24(12). 2749–2757. 38 indexed citations

Ajlan, Abdulrazag, et al.. (2017). Optimizing bevacizumab dosing in glioblastoma: less is more. Journal of Neuro-Oncology. 135(1). 99–105. 14 indexed citations

Zhu, Jay‐Jiguang, Santosh Kesari, & Lawrence D. Recht. (2015). Phase II Study of Verubulin (Azixa, MPC-6827) with Radiation Therapy and Temozolomide in Newly Diagnosed Glioblastoma Multiforme Patients: Incomplete Report on Safety, Tolerability and Responses (P3.125). Neurology. 84(14_supplement). 4 indexed citations

10.

Ajlan, Abdulrazag & Lawrence D. Recht. (2014). Supratentorial Low-Grade Diffuse Astrocytoma: Medical Management. Seminars in Oncology. 41(4). 446–457. 7 indexed citations

11.

Recht, Lawrence D., et al.. (2013). Steroid-Sparing Effect of Corticorelin Acetate in Peritumoral Cerebral Edema Is Associated With Improvement in Steroid-Induced Myopathy. Journal of Clinical Oncology. 31(9). 1182–1187. 26 indexed citations

12.

Nagpal, Seema & Lawrence D. Recht. (2011). Treatment and Prophylaxis of Hematologic Malignancy in the Central Nervous System. Current Treatment Options in Neurology. 13(4). 400–412. 7 indexed citations

13.

Glantz, Michael, et al.. (2009). Understanding the Origins of Gliomas and Developing Novel Therapies: Cerebrospinal Fluid and Subventricular Zone Interplay. Seminars in Oncology. 36(4 Suppl 2). S17–S24. 17 indexed citations

14.

Bredel, Markus, Claudia Bredel, Dejan Juric, et al.. (2005). High-Resolution Genome-Wide Mapping of Genetic Alterations in Human Glial Brain Tumors. Cancer Research. 65(10). 4088–4096. 126 indexed citations

15.

Bredel, Markus, Claudia Bredel, Dejan Juric, et al.. (2005). Functional Network Analysis Reveals Extended Gliomagenesis Pathway Maps and Three Novel MYC-Interacting Genes in Human Gliomas. Cancer Research. 65(19). 8679–8689. 249 indexed citations

16.

Colocci, Natalia, Michael Glantz, & Lawrence D. Recht. (2004). Prevention and Treatment of Central Nervous System Involvement by Non-Hodgkin's Lymphoma: A Review of the Literature. Seminars in Neurology. 24(4). 395–404. 34 indexed citations

17.

Griffin, Thomas W., et al.. (1993). Potentiation of Antitumor Immunotoxins by Liposomal Monensin. JNCI Journal of the National Cancer Institute. 85(4). 292–298. 36 indexed citations

18.

Recht, Lawrence D.. (1991). Neurologic Complications of Systemic Lymphoma. Neurologic Clinics. 9(4). 1001–1015. 40 indexed citations

19.

Recht, Lawrence D., Gitte Strauss, Thomas J. FitzGerald, et al.. (1990). Preirradiation Chemotherapy of Supratentorial Malignant Primary Brain Tumors with Intracarotid cis-Platinum (CDDP) and i.v. BCNU. American Journal of Clinical Oncology. 13(2). 125–131. 31 indexed citations

20.

Chad, David A. & Lawrence D. Recht. (1988). Neurological Paraneoplastic Syndromes. Cancer Investigation. 6(1). 67–82. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact